Matching strategies for drug studies of prepulse inhibition in humans

Behavioural Pharmacology

Volumn 12, Issue 1, 2001, Pages 45-52

  Swerdlow, N R ^a   Eastvold, A ^a   Uyan, K M ^a   Ploum, Y ^a   Cadenhead, K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Human; Prepulse inhibition; Startle reflex

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PLACEBO;

ADULT; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; DRUG EFFECT; EYELID REFLEX; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PREDICTION; PREPULSE INHIBITION; SENSORIMOTOR FUNCTION; STARTLE REFLEX; TACTILE STIMULATION;

EID: 0035095620     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200102000-00005     Document Type: Article

References (37)

1. Evidence for involvement of D2 dopamine receptors in prepulse inhibition of the startle reflex in man
2. Sensorimotor gating and habituation evoked by electrocutaneous stimulation in schizophrenia
3. Prestimulus effects on human startle reflex in normals and schizophrenics
4. Gating and habituation of the startle reflex in schizophrenic patients
5. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients
6. Impaired startle prepulse inhibition and habituation in schizotypal patients
7. Prepulse inhibition and habituation of the startle response are stable neurobiological measures in a normal male population
8. Modulation of the startle response and startle laterality in relatives of schizophrenia patients and schizotypal personality disordered subjects: Evidence of inhibitory deficits
9. The mammalian startle response
10. Habituation of the startle response under an incremental sequence of stimulus intensities
11. Ketamine effects on prepulse inhibition of startle in normals
12. Measurement of startle response, prepulse inhibition, and habituation
13. The more or less startling effects of weak prestimuli
14. Startle gating deficits occur across prepulse intensities in schizophrenic patients
15. Effect of D-amphetamine on prepulse inhibition of the startle reflex in humans
16. Personality factors moderate subjective and psychophysiological responses to d-amphetamine in humans
17. Protecting patients, preserving progress: Ethics in mental health illness research
18. The effect of ketamine on pre-pulse inhibition and attention
19. The acoustic startle response in rats: Circuits mediating evocation, inhibition and potentiation
20. Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers
21. Normalization of information processing deficits in schizophrenia with clozapine
22. Disorders of attention and perception in early schizophrenia
23. The effects of apomorphine and L-dopa challenge on prepulse inhibition in patients with Parkinson's disease
24. A relationship between inhibition of the acoustic startle response and the protection of prepulse processing
25. Time order error in successive judgements and in reflexes. I. Inhibition of the judgement and the reflex
26. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia
27. Neurophysiology and neuropharmacology of short lead interval startle modification
28. Neural substrates of sensorimotor gating of the startle reflex: A review of recent findings and their implications
29. Changes in sensorimotor inhibition across the menstrual cycle: Implications for neuropsychiatric disorders
30. Towards a cross-species pharmacology of sensorimotor gating: Effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats
31. Cross-species studies of sensorimotor gating of the startle reflex
32. Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: Impact of caffeine intake and withdrawal
33. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects
34. Opposite effects of 3,4-methylenedioxy-methamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans
35. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients